ImmunityBio Insider Trades
NASDAQ: IBRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 16 · $9.51M
- Shares bought / sold
- 0 / 1.04M
- Net activity
- Net selling $9.5 million
ImmunityBio insider activity
Over the last 12 months, ImmunityBio insiders reported 51 transactions on SEC Form 4: 0 open-market purchases and 16 sales. Insiders bought $0 and sold $9.5 million worth of stock, for net insider selling of $9.5 million. The largest seller was Simon Barry J., with $4.4 million in reported sales.
The most recent filing shows Simon Barry J. (Director) selling 25,000 shares at $10.75 on Oct 5, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put IBRX's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
IBRX insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 5, 2026 | Simon Barry J.Director | Sale | 25,000 | $268.76K | Form 4 |
| Oct 2, 2026 | Cohen CherylDirector | Sale | 81,056 | $851.09K | Form 4 |
| Oct 2, 2026 | Cohen CherylDirector | Option exercise | 55,979 | $166.82K | Form 4 |
| Jul 2, 2026 | Cohen CherylDirector | Sale | 131,210 | $1.25M | Form 4 |
| Jul 2, 2026 | Cohen CherylDirector | Option exercise | 55,979 | $166.82K | Form 4 |
| Jul 1, 2026 | Selecky ChristobelDirector | Sale | 159,478 | $1.44M | Form 4 |
| Jul 1, 2026 | Selecky ChristobelDirector | Option exercise | 124,414 | $372.00K | Form 4 |
| Jul 1, 2026 | Selecky ChristobelDirector | Option exercise | 35,064 | $104.49K | Form 4 |
| Jun 30, 2026 | Selecky ChristobelDirector | Sale | 1,000 | $9.00K | Form 4 |
| Jun 30, 2026 | Selecky ChristobelDirector | Option exercise | 300 | $897 | Form 4 |
| Jun 30, 2026 | Selecky ChristobelDirector | Option exercise | 700 | $2.09K | Form 4 |
| Jun 29, 2026 | Selecky ChristobelDirector | Sale | 95,722 | $862.22K | Form 4 |
| Jun 29, 2026 | Selecky ChristobelDirector | Option exercise | 30,000 | $85.20K | Form 4 |
| Jun 29, 2026 | Selecky ChristobelDirector | Option exercise | 33,549 | $100.31K | Form 4 |
| Jun 29, 2026 | Selecky ChristobelDirector | Option exercise | 32,173 | $95.88K | Form 4 |
| Jun 24, 2026 | Simon Barry J.Director | Sale | 25,000 | $196.91K | Form 4 |
| Jun 4, 2026 | Simon Barry J.Director | Sale | 23,033 | $165.31K | Form 4 |
| Mar 31, 2026 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & Cambridge Equities, LP & MP 13 Ventures, LLC & Nant Capital, LLCSee remarks | Conversion | 4,606,596 | $25.00M | Form 4 |
| Feb 24, 2026 | Simon Barry J.Director | Sale | 75,000 | $900.79K | Form 4 |
| Feb 23, 2026 | Simon Barry J.Director | Sale | 165,000 | $1.69M | Form 4 |
| Feb 23, 2026 | Selecky ChristobelDirector | Sale | 25,000 | $250.00K | Form 4 |
| Feb 23, 2026 | Selecky ChristobelDirector | Option exercise | 25,000 | $74.50K | Form 4 |
| Feb 22, 2026 | Adcock RichardCEO & President | Tax withholding | 77,560 | $674.77K | Form 4 |
| Feb 22, 2026 | Adcock RichardCEO & President | Option exercise | 152,439 | — | Form 4 |
| Feb 22, 2026 | LAUER REGAN JChief Accounting Officer | Tax withholding | 1,673 | $14.56K | Form 4 |
| Feb 22, 2026 | LAUER REGAN JChief Accounting Officer | Option exercise | 4,065 | — | Form 4 |
| Feb 22, 2026 | Simon Barry J.Director | Tax withholding | 6,026 | $52.43K | Form 4 |
| Feb 22, 2026 | Simon Barry J.Director | Option exercise | 15,243 | — | Form 4 |
| Feb 22, 2026 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & Cambridge Equities, LP & MP 13 Ventures, LLC & Nant Capital, LLCSee remarks | Tax withholding | 58,170 | $506.08K | Form 4 |
| Feb 22, 2026 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & Cambridge Equities, LP & MP 13 Ventures, LLC & Nant Capital, LLCSee remarks | Option exercise | 114,329 | — | Form 4 |
| Feb 22, 2026 | Sachs David C.Chief Financial Officer | Tax withholding | 20,682 | $179.93K | Form 4 |
| Feb 22, 2026 | Sachs David C.Chief Financial Officer | Option exercise | 40,650 | — | Form 4 |
| Feb 20, 2026 | Simon Barry J.Director | Sale | 10,000 | $92.50K | Form 4 |
| Feb 10, 2026 | LAUER REGAN JChief Accounting Officer | Tax withholding | 2,257 | $15.64K | Form 4 |
| Feb 10, 2026 | LAUER REGAN JChief Accounting Officer | Option exercise | 5,482 | — | Form 4 |
| Feb 10, 2026 | Sachs David C.Chief Financial Officer | Tax withholding | 42,643 | $295.52K | Form 4 |
| Feb 10, 2026 | Sachs David C.Chief Financial Officer | Option exercise | 82,236 | — | Form 4 |
| Feb 10, 2026 | Adcock RichardCEO & President | Tax withholding | 140,048 | $970.53K | Form 4 |
| Feb 10, 2026 | Adcock RichardCEO & President | Option exercise | 274,122 | — | Form 4 |
| Feb 10, 2026 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & Cambridge Equities, LP & MP 13 Ventures, LLC & Nant Capital, LLCSee remarks | Tax withholding | 118,560 | $821.62K | Form 4 |
| Feb 10, 2026 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & Cambridge Equities, LP & MP 13 Ventures, LLC & Nant Capital, LLCSee remarks | Option exercise | 274,122 | — | Form 4 |
| Jan 20, 2026 | Selecky ChristobelDirector | Sale | 25,000 | $187.65K | Form 4 |
| Jan 20, 2026 | Selecky ChristobelDirector | Option exercise | 25,000 | $74.50K | Form 4 |
| Jan 20, 2026 | Simon Barry J.Director | Sale | 75,000 | $590.93K | Form 4 |
| Jan 20, 2026 | Simon Barry J.Director | Sale | 76,967 | $503.36K | Form 4 |
| Jan 16, 2026 | Selecky ChristobelDirector | Sale | 50,000 | $250.00K | Form 4 |
| Jan 16, 2026 | Selecky ChristobelDirector | Option exercise | 50,000 | $149.00K | Form 4 |
| Dec 31, 2025 | Adcock RichardCEO & President | Tax withholding | 17,510 | $34.67K | Form 4 |
| Dec 31, 2025 | Adcock RichardCEO & President | Option exercise | 34,483 | — | Form 4 |
| Dec 31, 2025 | Sachs David C.Chief Financial Officer | Tax withholding | 15,435 | $30.56K | Form 4 |
| Dec 31, 2025 | Sachs David C.Chief Financial Officer | Option exercise | 30,397 | — | Form 4 |
| Feb 22, 2025 | Simon Barry J.Director | Tax withholding | 5,453 | $18.65K | Form 4 |
| Feb 22, 2025 | Simon Barry J.Director | Option exercise | 15,243 | — | Form 4 |
| Feb 22, 2025 | Sachs David C.Chief Financial Officer | Tax withholding | 15,860 | $54.24K | Form 4 |
| Feb 22, 2025 | Sachs David C.Chief Financial Officer | Option exercise | 40,650 | — | Form 4 |
| Feb 22, 2025 | LAUER REGAN JChief Accounting Officer | Tax withholding | 1,669 | $5.71K | Form 4 |
| Feb 22, 2025 | LAUER REGAN JChief Accounting Officer | Option exercise | 4,065 | — | Form 4 |
| Feb 22, 2025 | Adcock RichardCEO & President | Tax withholding | 78,167 | $267.33K | Form 4 |
| Feb 22, 2025 | Adcock RichardCEO & President | Option exercise | 152,439 | — | Form 4 |
| Feb 22, 2025 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & MP 13 Ventures, LLC & Cambridge Equities, LP & Nant Capital, LLCSee remarks | Tax withholding | 42,071 | $143.88K | Form 4 |
| Feb 22, 2025 | SOON-SHIONG PATRICK & CALIFORNIA CAPITAL EQUITY, LLC & MP 13 Ventures, LLC & Cambridge Equities, LP & Nant Capital, LLCSee remarks | Option exercise | 114,329 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4